Immuneering

6.13
-0.11
-1.76%
IMRX
高 6.42开 6.27量 185.31万股总市值 3.71亿
低 6.03换 3.06%额 1141.67万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Immuneering(IMRX)
10-08 03:55  
$Immuneering(IMRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-002312  Act: 34  Size: 11 KB 网页链接
用户头像
Immuneering(IMRX)
10-07 21:05  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000127  Size: 6 KB 网页链接
用户头像
Immuneering(IMRX)
10-04 04:25  
$Immuneering(IMRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-096664  Act: 34  Size: 7 KB 网页链接
用户头像
Immuneering(IMRX)
10-02 21:05  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000123  Size: 4 KB 网页链接
用户头像
Immuneering(IMRX)
10-02 21:05  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000125  Size: 4 KB 网页链接
用户头像
Immuneering(IMRX)
10-02 20:55  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000121  Size: 4 KB 网页链接
用户头像
Immuneering(IMRX)
10-01 21:05  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000119  Size: 7 KB 网页链接
用户头像
Immuneering(IMRX)
09-30 21:05  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000117  Size: 6 KB 网页链接
用户头像
Immuneering(IMRX)
09-26 05:35  
$Immuneering(IMRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-093438  Act: 33  Size: 601 KB 网页链接
用户头像
Immuneering(IMRX)
09-26 05:25  
$Immuneering(IMRX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-25-093436  Act: 34  Size: 497 KB 网页链接
用户头像
Immuneering(IMRX)
09-25 18:15  
$Immuneering(IMRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-25-093059  Act: 34  Size: 20 KB 网页链接
用户头像
Immuneering(IMRX)
09-25 05:15  
$Immuneering(IMRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-092991  Act: 33  Size: 644 KB 网页链接
用户头像
Immuneering(IMRX)
09-25 05:15  
$Immuneering(IMRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-25-092993  Act: 34  Size: 39 KB 网页链接
用户头像
Immuneering(IMRX)
09-25 04:25  
$Immuneering(IMRX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-25-092957  Act: 34  Size: 566 KB 网页链接
用户头像
Immuneering(IMRX)
09-23 20:55  
$Immuneering(IMRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-006155  Act: 33  Size: 4 KB 网页链接
用户头像
Immuneering(IMRX)
09-18 04:45  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000113  Size: 5 KB 网页链接
用户头像
Immuneering(IMRX)
09-18 04:45  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000115  Size: 5 KB 网页链接
用户头像
Immuneering(IMRX)
09-18 04:35  
$Immuneering(IMRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001790340-25-000111  Size: 5 KB 网页链接
用户头像
Immuneering(IMRX)
09-10 04:55  
$Immuneering(IMRX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001790340-25-000105  Act: 33  Size: 10 KB 网页链接
用户头像
Immuneering(IMRX)
09-09 18:15  
$Immuneering(IMRX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002880  Act: 33  Size: 1 KB 网页链接